| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |